The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation

Blood

Volumn 96, Issue 2, 2000, Pages 554-559

  Franco, Rendrik F ^a   De Jonge, Evert ^a   Dekkers, Pascale E P ^a   Timmerman, Janneke J ^a   Spek, C Arnold ^a   Van Deventer, Sander J H ^a   Van Deursen, Peter ^a   Van Kerkhoff, Liesbeth ^a   Van Gemen, Bob ^a   Ten Cate, Hugo ^a   Van Der Poll, Tom ^a   Reitsma, Pieter H ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING; CHEMOLUMINESCENCE; ENDOTOXEMIA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THROMBIN TIME;

EID: 0034662157     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.2.554     Document Type: Article

References (35)

1. Petersen LC, Valentin S, Hedner U. Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor. Thromb Res. 1995;79:1-47.
2. Burell R. Human responses to bacterial endotoxin. Circ Shock. 1994;43:137-153.
3. Pajkrt D, van der Poll T, Levi M, et al. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood. 1997; 89:2701-2705.
4. ten Cate H, Levi M, van der Poll T, et al. Inhibition of extrinsic coagulation activation in endotoxemia: therapeutic implications. Prog Clin Biol Res. 1994;388:215-219.
5. van der Poll T, Lowry SF. Biological responses to endotoxin in humans. In: Tellado JM, Forse RA, Solomkin JS, eds. Modulation of the Inflammatory Response in Severe Sepsis. Basel, Switzerland: Karger; 1995:18-32.
6. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood. 1990;76:2520-2526.
7. Biemond BJ, Levi M, ten Cate H, et al. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemost. 1995;73:223-230.
8. Carr C, Bild GS, Chang AC, et al. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock. 1994;44:126-137.
9. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest. 1993;91:2850-2856.
10. Dackiw APB, McGilvray ID, Woodside M, Nathens AB, Marshall JC, Rotstein OD. Prevention of endotoxin-induced mortality by anti-tissue factor immunization. Arch Surg. 1996;131:1273-1279.
11. Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifyline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994;93:114-120.
12. Taylor Jr FB, Chang A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991; 33:127-134.
13. Taylor Jr FB. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of protein C, S, C4bBP, and of inhibitors of tissue factor. Prog Clin Biol Res. 1994;388: 175-194.
14. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995;73:10-13.
15. Amirkhosravi A, Alexander M, May K, et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new blood flow cytometric assay. Thromb Haemost. 1996;75:87-95.
16. Agraou B, Corseaux D, McFadden EP, Bauters A, Cosson A, Jude B. Effects of coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina. Thromb Res. 1997;88:237-243.
17. Misumi K, Ogawa H, Yasue H, et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol. 1996;81:22-26.
18. Van der Poll T, Coyle SM, Levi M, et al. Fat emulsion infusion potentiates coagulation activation during human endotoxemia. Thromb Haemost. 1996;75:83-86.
19. Busso N, Huet S, Nicodème E, Hiernaux J, Hyafil F. Refractory period phenomenon in the induction of tissue factor expression on endothelial cells. Blood. 1991;78:2027-2035.
20. Crossman DC, Carr DP, Tuddenham EG, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990; 265:9782-9787.
21. Dedrick RL, Conlon PJ. Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS. Infect Immun. 1995;63:1362-1368.
22. Gallay P, Jongeneel CV, Barras C, et al. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J Immunol. 1993; 11:5086-5093.
23. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9:2752-2755.
24. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987;79:124-130.
25. Steinemann S, Ulevitch RJ, Mackman N. Role of the lipopolysaccharide (LPS)-binding protein/ CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb. 1994;14:1202-1209.
26. Ternisien C, Ramani M, Ollivier V, et al. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost. 1993;70:800-806.
27. Van der Logt CP, Dirven RJ, Reitsma PH, Bertina RM. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester Blood Coagul Fibrinolysis. 1994;5:211-220.
28. Compton J. Nucleic acid sequence-based amplification. Nature. 1991;350:91-92.
29. Blackburn GF, Shah HP, Kenten JH, et al. Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics. Clin Chem. 1991;37:1534-1539.
30. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, Noordaa van der J. A rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495-503.
31. Kievits T, van Gemen B, van Strijp D, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods. 1991;35:273-286.
32. Kenten JH, Gudibande S, Link J, et al. Improved electrochemiluminescent label for DNA probe assays: rapid quantitative assays of HIV-1 polymerase chain reaction products. Clin Chem. 1992;38: 873-879.
33. Penn MS, Patel CV, Mei-Zhen C, DiCorleto PE, Chisolm GM. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces. Circulation. 1999;99:1753-1759.
34. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96,2311-2315.
35. Taylor FB, Chang AC, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood. 1998;91:1609-1615.